Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 4;10:959. doi: 10.3389/fphar.2019.00959

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Shen, Ma, Li, Liu, Chen, Wei, Liu, Hou, Xiong and Yang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

R. tanguticum nanoparticles inhibition of HSV-1 replication. (A) HEp-2 cells in 96-well plates were treated with serial dilution of R. tanguticum nanoparticles for 72 h and the viability were measured by the MTT assay. (B) Inhibitory effects of R. tanguticum nanoparticles on HSV-1 infection. HEp-2 cells infected with HSV-1 were treated with different concentrations of R. tanguticum nanoparticles and were subjected to the plaque reduction assay. (C) Time-of-addition assay. HEp-2 cells were infected with HSV-1 and then treated with R. tanguticum nanoparticles (350 µg/ml) at indicated intervals. The progeny virus yields were determined by plaque assay. Values are represented as the mean ± standard deviation of three individual experiments. “VC” is the abbreviation of the “virus control group”.*p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.

HHS Vulnerability Disclosure